\-\ Texto\\:\\ \ \(0\)\
\-\ diffuse\\ ttp\\,\\ soft\\,\\ non\\-distended\\,\\ \\+bs\\,\\ no\\ hsm\\,\\ no\\ rebound\\ tenderness\\.\ \(0\)\
\-\ ct\\ demonstrates\\ homogeneous\\ density\\ of\\ thickened\\ bowel\\ wall\\ with\\ intestinal\\ lumen\\ surrounded\\ by\\ edematous\\ mucosa\\.\\ \\ the\\ distal\\ jejunum\\ and\\ terminal\\ ileum\\ were\\ involve\\.\\ \\ intervening\\ segments\\ of\\ bowel\\ were\\ unremarkable\\.\ \(0\)\
\-\ subsequent\\ colonoscopy\\ demonstrated\\ nodularity\\ within\\ the\\ terminal\\ ileum\\.\ \(0\)\
\-\ small\\ bowel\\ follow\\ through\\ revealed\\ delayed\\ transit\\ time\\ with\\ persistent\\ narrowing\\ and\\ thickening\\ of\\ the\\ distal\\ jejunum\\ and\\ terminal\\ ileum\\.\ \(0\)\
\-\ crohns\\ disease\ \(0\)\
\-\ thickened\\ small\\ bowel\\ \\ folds\\ are\\ nonspecific\\ and\\ can\\ be\\ seen\\ in\\ a\\ wide\\ variety\\ of\\ condtions\\,\\ including\\ \\:\\ inflammatory\\ bowel\\ dieseae\\,\\ other\\ inflammatory\\ conditions\\,\\ ischemia\\,\\ hemorrhage\\,infection\\ \\(tb\\,\\ celiac\\)\\.\\ neoplasm\\ \\(lymphoma\\,\\ carcniod\\,\\ adenocarcinoma\\)\\ and\\ amyloidosis\\.\ \(0\)\
\-\ decreased\\ small\\ bowel\\ transit\\ time\\ is\\ possible\\ in\\:\\ inflammatory\\ bowel\\ dieseae\\,\\ hypothyroidism\\,\\ diabetes\\,\\ scleroderma\\,\\ opiate\\ use\\ or\\ celiac\\ disease\\.\ \(0\)\
\-\ 19\\ year\\-old\\ male\\ with\\ epigastric\\ abdominal\\ pain\\ and\\ hematochezia\\.\ \(1\)\
\-\ crohns\\ disease\\ is\\ an\\ idiopathic\\ inflammatory\\ process\\ which\\ can\\ involve\\ any\\ part\\ of\\ the\\ gi\\ tract\\ from\\ the\\ esophagus\\ to\\ rectum\\ \\(small\\ bowel\\-80\\%\\)\\.\\ \\ this\\ patient\\'s\\ findings\\ are\\ limited\\ to\\ the\\ distal\\ jejunum\\ and\\ terminal\\ ileum\\.\\ \\ these\\ findings\\ constitue\\ \\"skip\\ lesions\\"\\,\\ or\\ discontinous\\ involvement\\ of\\ bowel\\ segments\\,\\ with\\ normal\\ intervening\\ bowel\\.\ \(0\)\
\-\ crohns\\ can\\ be\\ categorized\\ into\\ 3\\ phases\\:\\ early\\,\\ advanced\\ and\\ stenotic\\.\\ \\ this\\ patient\\'s\\ presentation\\ is\\ most\\ consistent\\ with\\ the\\ early\\ phase\\ which\\ includes\\ nodular\\ enlargement\\ of\\ lymphoid\\ follices\\ with\\ obstructive\\ lyphedema\\ fist\\ arising\\ in\\ the\\ t\\.i\\.\\.\\ \\ later\\,\\ \\"advanced\\"\\ findings\\ may\\ include\\ \\ coboblestoning\\ and\\ lumenal\\ narrowing\\.\\ \\ the\\ final\\ or\\ \\"stenotic\\ phase\\"\\ involve\\ strictures\\ with\\ dilated\\ proximal\\ loops\\.\ \(0\)\
\-\ crohns\\ disease\\ can\\ exhibit\\ many\\ extraintestinal\\ manifestations\\ including\\ hepatobiliary\\,\\ gu\\,\\ msk\\ findings\\.\\ \\ this\\ young\\ patient\\ did\\ not\\ demonstrate\\ any\\ of\\ these\\ at\\ this\\ point\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ crohns\\:\\ 0\\.08115804773797448\ \(0\)\
\-\ bowel\\:\\ 0\\.07513888409957269\ \(0\)\
\-\ terminal\\:\\ 0\\.06110274664845298\ \(0\)\
\-\ ileum\\:\\ 0\\.059690551192914\ \(0\)\
\-\ dieseae\\:\\ 0\\.054925348435928334\ \(0\)\
\-\ jejunum\\:\\ 0\\.054869901353271563\ \(0\)\
\-\ intervening\\:\\ 0\\.041235475679939425\ \(0\)\
\-\ involve\\:\\ 0\\.03764510916994815\ \(0\)\
\-\ transit\\:\\ 0\\.037272928846793035\ \(0\)\
\-\ inflammatory\\:\\ 0\\.03692605537933986\ \(0\)\
\-\ stenotic\\:\\ 0\\.03657993423551438\ \(0\)\
\-\ celiac\\:\\ 0\\.032773647118237284\ \(0\)\
\-\ segments\\:\\ 0\\.02995754042824939\ \(0\)\
\-\ condtions\\:\\ 0\\.027462674217964167\ \(0\)\
\-\ carcniod\\:\\ 0\\.027462674217964167\ \(0\)\
\-\ bowel\\-80\\:\\ 0\\.027462674217964167\ \(0\)\
\-\ constitue\\:\\ 0\\.027462674217964167\ \(0\)\
\-\ discontinous\\:\\ 0\\.027462674217964167\ \(0\)\
\-\ follices\\:\\ 0\\.027462674217964167\ \(0\)\
\-\ lyphedema\\:\\ 0\\.027462674217964167\ \(0\)\
\-\ t\\.i\\:\\ 0\\.027462674217964167\ \(0\)\
\-\ coboblestoning\\:\\ 0\\.027462674217964167\ \(0\)\
\-\ advanced\\:\\ 0\\.027245278302032282\ \(0\)\
\-\ phase\\:\\ 0\\.025045033510091942\ \(0\)\
\-\ small\\:\\ 0\\.024530533138705526\ \(0\)\
\-\ can\\:\\ 0\\.024152303457558498\ \(0\)\
\-\ extraintestinal\\:\\ 0\\.02404020602896694\ \(0\)\
\-\ thickened\\:\\ 0\\.023874839889458953\ \(0\)\
\-\ opiate\\:\\ 0\\.023144000195783825\ \(0\)\
\-\ lumenal\\:\\ 0\\.023144000195783825\ \(0\)\
\-\ findings\\:\\ 0\\.02266463471389358\ \(0\)\
\-\ hepatobiliary\\:\\ 0\\.02188086901787677\ \(0\)\
\-\ distal\\:\\ 0\\.02171288400884137\ \(0\)\
\-\ skip\\:\\ 0\\.021400648831499017\ \(0\)\
\-\ fist\\:\\ 0\\.021400648831499017\ \(0\)\
\-\ narrowing\\:\\ 0\\.021348577533644844\ \(0\)\
\-\ msk\\:\\ 0\\.02098466318469365\ \(0\)\
\-\ hsm\\:\\ 0\\.019721532006786596\ \(0\)\
\-\ categorized\\:\\ 0\\.019721532006786596\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.01962743025824128\ \(0\)\
\-\ \\+bs\\:\\ 0\\.019472177777274023\ \(0\)\
\-\ early\\:\\ 0\\.019471395449485594\ \(0\)\
\-\ \\,\\:\\ 0\\.01939667136105174\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.019249995345628438\ \(0\)\
\-\ including\\:\\ 0\\.019223792155719153\ \(0\)\
\-\ hematochezia\\:\\ 0\\.019026380756586567\ \(0\)\
\-\ lymphoid\\:\\ 0\\.01882532617360348\ \(0\)\
\-\ \\.\\.\\:\\ 0\\.017694779464290804\ \(0\)\
\-\ exhibit\\:\\ 0\\.017694779464290804\ \(0\)\
\-\ phases\\:\\ 0\\.017435023673203418\ \(0\)\
\-\ strictures\\:\\ 0\\.017435023673203418\ \(0\)\
\-\ gu\\:\\ 0\\.017435023673203418\ \(0\)\
\-\ disease\\:\\ 0\\.017404829174027466\ \(0\)\
\-\ scleroderma\\:\\ 0\\.016867043745496392\ \(0\)\
\-\ any\\:\\ 0\\.01676532730886164\ \(0\)\
\-\ nodularity\\:\\ 0\\.016764894764739413\ \(0\)\
\-\ non\\-distended\\:\\ 0\\.016665989162513307\ \(0\)\
\-\ amyloidosis\\:\\ 0\\.016665989162513307\ \(0\)\
\-\ edematous\\:\\ 0\\.01629906381778937\ \(0\)\
\-\ folds\\:\\ 0\\.016130630106667015\ \(0\)\
\-\ variety\\:\\ 0\\.015745539901161794\ \(0\)\
\-\ hypothyroidism\\:\\ 0\\.015603912567589341\ \(0\)\
\-\ epigastric\\:\\ 0\\.015603912567589341\ \(0\)\
\-\ colonoscopy\\:\\ 0\\.015535442453200633\ \(0\)\
\-\ surrounded\\:\\ 0\\.01521399623439929\ \(0\)\
\-\ manifestations\\:\\ 0\\.015153503755093677\ \(0\)\
\-\ ttp\\:\\ 0\\.01509416358384541\ \(0\)\
\-\ intestinal\\:\\ 0\\.01509416358384541\ \(0\)\
\-\ time\\:\\ 0\\.015038013876880451\ \(0\)\
\-\ rectum\\:\\ 0\\.014867498928759963\ \(0\)\
\-\ final\\:\\ 0\\.014363943316434681\ \(0\)\
\-\ wide\\:\\ 0\\.014272311275293577\ \(0\)\
\-\ mucosa\\:\\ 0\\.014054371746923141\ \(0\)\
\-\ rebound\\:\\ 0\\.013930570100039919\ \(0\)\
\-\ these\\:\\ 0\\.01385573016796162\ \(0\)\
\-\ nonspecific\\:\\ 0\\.013696815626697507\ \(0\)\
\-\ obstructive\\:\\ 0\\.013696815626697507\ \(0\)\
\-\ conditions\\:\\ 0\\.013243520973516082\ \(0\)\
\-\ diabetes\\:\\ 0\\.013179286433943694\ \(0\)\
\-\ loops\\:\\ 0\\.013054659223309117\ \(0\)\
\-\ part\\:\\ 0\\.012905575045185644\ \(0\)\
\-\ lumen\\:\\ 0\\.012819433203034521\ \(0\)\
\-\ tb\\:\\ 0\\.012819433203034521\ \(0\)\
\-\ homogeneous\\:\\ 0\\.012600728347354621\ \(0\)\
\-\ ischemia\\:\\ 0\\.012371748714977903\ \(0\)\
\-\ 19\\:\\ 0\\.012275143616091423\ \(0\)\
\-\ idiopathic\\:\\ 0\\.012135630835322035\ \(0\)\
\-\ were\\:\\ 0\\.012089011443550911\ \(0\)\
\-\ this\\:\\ 0\\.01197678770484901\ \(0\)\
\-\ gi\\:\\ 0\\.011958830783632161\ \(0\)\
\-\ tract\\:\\ 0\\.011791528045402063\ \(0\)\
\-\ \\'s\\:\\ 0\\.01173860821412489\ \(0\)\
\-\ point\\:\\ 0\\.011632754077825654\ \(0\)\
\-\ young\\:\\ 0\\.011594293530092635\ \(0\)\
\-\ esophagus\\:\\ 0\\.011556302025127469\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.011500169609231274\ \(0\)\
\-\ limited\\:\\ 0\\.011233745392913013\ \(0\)\
\-\ nodular\\:\\ 0\\.011166385691937418\ \(0\)\
\-\ arising\\:\\ 0\\.011019949422853522\ \(0\)\
\-\ many\\:\\ 0\\.010941475127437454\ \(0\)\
\-\ delayed\\:\\ 0\\.010834829732913333\ \(0\)\
\-\ includes\\:\\ 0\\.010731714628781419\ \(0\)\
\-\ persistent\\:\\ 0\\.010617902344256634\ \(0\)\
\-\ \\:\\:\\ 0\\.010563316037295933\ \(0\)\
\-\ enlargement\\:\\ 0\\.010562518400265094\ \(0\)\
\-\ use\\:\\ 0\\.010521617180820257\ \(0\)\
\-\ subsequent\\:\\ 0\\.0103631797439558\ \(0\)\
\-\ process\\:\\ 0\\.01024942518640098\ \(0\)\
\-\ which\\:\\ 0\\.009938595559143606\ \(0\)\
\-\ year\\-old\\:\\ 0\\.009778082933639303\ \(0\)\
\-\ involvement\\:\\ 0\\.009756818244946468\ \(0\)\
\-\ dilated\\:\\ 0\\.009673181951998842\ \(0\)\
\-\ later\\:\\ 0\\.009611896077859576\ \(0\)\
\-\ did\\:\\ 0\\.009611896077859576\ \(0\)\
\-\ or\\:\\ 0\\.009360025691249602\ \(0\)\
\-\ presentation\\:\\ 0\\.009169472381592157\ \(0\)\
\-\ neoplasm\\:\\ 0\\.00906590833617423\ \(0\)\
\-\ thickening\\:\\ 0\\.009023752553561843\ \(0\)\
\-\ possible\\:\\ 0\\.008965676694342903\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.008860612411763351\ \(0\)\
\-\ unremarkable\\:\\ 0\\.008813291023931653\ \(0\)\
\-\ density\\:\\ 0\\.008758976189594888\ \(0\)\
\-\ revealed\\:\\ 0\\.00854353236718409\ \(0\)\
\-\ follow\\:\\ 0\\.008458565333166461\ \(0\)\
\-\ be\\:\\ 0\\.008210322263825103\ \(0\)\
\-\ tenderness\\:\\ 0\\.008096300071282347\ \(0\)\
\-\ diffuse\\:\\ 0\\.00805921314758665\ \(0\)\
\-\ patient\\:\\ 0\\.008005532064639139\ \(0\)\
\-\ proximal\\:\\ 0\\.00799234636045799\ \(0\)\
\-\ decreased\\:\\ 0\\.007915128980450341\ \(0\)\
\-\ demonstrated\\:\\ 0\\.007811277203915786\ \(0\)\
\-\ infection\\:\\ 0\\.007738369389634913\ \(0\)\
\-\ wall\\:\\ 0\\.007710776075510113\ \(0\)\
\-\ lymphoma\\:\\ 0\\.007608095434235158\ \(0\)\
\-\ through\\:\\ 0\\.007560613764550993\ \(0\)\
\-\ include\\:\\ 0\\.007467767875483759\ \(0\)\
\-\ are\\:\\ 0\\.0072577811372560854\ \(0\)\
\-\ lesions\\:\\ 0\\.0071263567175823914\ \(0\)\
\-\ \\(\\:\\ 0\\.006751044170503369\ \(0\)\
\-\ \\)\\:\\ 0\\.006668576561806589\ \(0\)\
\-\ abdominal\\:\\ 0\\.006653954012841481\ \(0\)\
\-\ consistent\\:\\ 0\\.0065274089371688574\ \(0\)\
\-\ soft\\:\\ 0\\.006482637894060904\ \(0\)\
\-\ into\\:\\ 0\\.0063343500559492425\ \(0\)\
\-\ 3\\:\\ 0\\.006233568619023488\ \(0\)\
\-\ \\%\\:\\ 0\\.0062097228453146655\ \(0\)\
\-\ most\\:\\ 0\\.006145903868311763\ \(0\)\
\-\ other\\:\\ 0\\.006135945634587067\ \(0\)\
\-\ demonstrate\\:\\ 0\\.006126019131878631\ \(0\)\
\-\ may\\:\\ 0\\.005839029186598516\ \(0\)\
\-\ demonstrates\\:\\ 0\\.0058150193197918565\ \(0\)\
\-\ no\\:\\ 0\\.005361022745818081\ \(0\)\
\-\ seen\\:\\ 0\\.005260522165319907\ \(0\)\
\-\ is\\:\\ 0\\.005255054003595566\ \(0\)\
\-\ within\\:\\ 0\\.005078290991856952\ \(0\)\
\-\ and\\:\\ 0\\.00504698146912762\ \(0\)\
\-\ male\\:\\ 0\\.004813724417094932\ \(0\)\
\-\ by\\:\\ 0\\.0044326196362768685\ \(0\)\
\-\ normal\\:\\ 0\\.00417324752211558\ \(0\)\
\-\ from\\:\\ 0\\.003945282595495988\ \(0\)\
\-\ in\\:\\ 0\\.003938291870469672\ \(0\)\
\-\ the\\:\\ 0\\.0038761481692605364\ \(0\)\
\-\ not\\:\\ 0\\.003846787139382976\ \(0\)\
\-\ ct\\:\\ 0\\.003723687393744682\ \(0\)\
\-\ an\\:\\ 0\\.0036811989541580365\ \(0\)\
\-\ at\\:\\ 0\\.0036067387938680156\ \(0\)\
\-\ pain\\:\\ 0\\.003251115786700108\ \(0\)\
\-\ of\\:\\ 0\\.002903521515214665\ \(0\)\
\-\ to\\:\\ 0\\.0026608604887413474\ \(0\)\
\-\ with\\:\\ 0\\.0025514929365396516\ \(0\)\
\-\ \\.\\:\\ 0\\.0019906281923745576\ \(0\)\
\-\ a\\:\\ 0\\.0012355134013040537\ \(0\)\
